Profiles of matrix metalloproteinase activity in equine tear fluid during corneal healing in 10 horses with ulcerative keratitis

Veterinary Ophthalmology

Volumn 7, Issue 6, 2004, Pages 397-405

  Ollivier, F J ^a   Brooks, D E ^a   Van Setten, G B ^b   Schultz, G S ^c   Gelatt, K N ^a   Stevens, G R ^d   Blalock, T D ^c   Andrew, S E ^f   Komaromy, A M ^e   Lassaline, M E ^a   Kallberg, M E ^a   Cutler, T J ^g  

^a Depts Large Small Anim Clin Sci   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF FLORIDA   (United States)

^d University of Florida   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f Georgia Veterinary Specialists   (United States)

^g Animal Eye Specialty Clinic   (United States)

Author keywords

Corneal healing; Corneal ulceration; Horse; Matrix metalloproteinase; Tear fluid

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ATROPINE; COLLAGEN; CORTICOSTEROID; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORNEA; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HEALING; HORSE; HOSPITAL ADMISSION; KERATITIS; LACRIMAL FLUID; MALE; MEASUREMENT; NONHUMAN; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; SERUM; STROMA; SURGICAL TECHNIQUE; ULCER; ZYMOGRAPHY;

ANIMALS; CORNEAL DISEASES; CORNEAL ULCER; FEMALE; HORSE DISEASES; HORSES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; TEARS; WOUND HEALING;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 9344239304     PISSN: 14635216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2004.04052.x     Document Type: Article

References (40)

1. Twining SS. Regulation of proteolytic activity in tissues. Critical Review of Biochemistry and Molecular Biology 1994; 29: 315-383.
2. Slansky HH, Gnadinger MC, Itoi M et al. Collagenase in corneal ulcerations. Archives of Ophthalmology 1969; 82: 108-111.
3. Hibbetts K et al. An overview of Proteinase inhibitors. Journal of Veterinary International Medicine 1999; 13: 302-308.
4. Matsubara M, Girard MT, Kublin CL et al. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Developments in Biology 1991; 147: 425-439.
5. Fini ME, Girard MT. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Investigative Ophthalmology ami Visual Sciences 1990; 31: 1779-1788.
6. Strubbe DT, Brooks DE, Schultz GS et al. Evaluation of tear film proteinases in horses with ulcerative keratitis. Veterinary Ophthalmology 2000; 3: 111-119.
7. Matsumoto K, Shams NB, Hanninen LA et al. Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases. Investigative Ophthalmology and Visual Sciences 1993; 34: 1945-1953.
8. Tervo T, Salonen EM, Vahen A et al. Elevation of tear fluid plasmin in corneal disease. Acta Ophthalmologica (Copenhagen) 1988; 66: 393-399.
9. Tervo T, van Setten GB, Joutsimo L et al. Recommendations on the collection of tear fluid for investigations of the fibrinolytic system. Experimental Eye Research 1991; 53: 809.
10. Prause JU. Serum albumin, serum antiproteases and polymorphonuclear leucocyte neutral collagenolytic protease in the tear fluid of patients with corneal ulcers. Acta Ophthalmologica (Copenhagen) 1983; 61: 272-282.
11. Prause JU. Serum antiproteases and polymorphonuclear leucocyte neutral collagenolytic protease in the tear fluid of patients with corneal ulcers treated with n-butylcyano acrylate glue. Acta Ophthalmologica (Copenhagen) 1983; 61: 283-291.
12. Berman M, Leary R, Gage J. Latent collagenase in the ulcerating rabbit cornea. Experimental Eye Research 1977; 25: 435-445.
13. Berman M, Dohlman CH, Gnadinger M et al. Characterization of collagenolytic activity in the ulcerating cornea. Experimental Eye Research 1971; 11: 255-257.
14. Berman MB, Manabe R. Corneal collagenases: evidence for zinc metalloenzymes. Annals of Ophthalmology 1973; 5: 1193-1195.
15. Berman MB, Kerza-Kwiatecki AP, Davison PF, Characterization of human corneal collagenase. Experimental Eye Research 1973; 15: 367-373.
16. Brooks DE. Equine ophthalmology. In: Veterinary Ophthalmology, 3rd edn. (ed. Gelatt KN) Lippincott/Williams & Wilkins, Philadelphia, 1999; 1053-1116.
17. Lobmann R, Ambrosch A, Schultz G et al. Expression of matrix-metal loproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-1016.
18. Herouy Y. Matrix metalloproteinases in skin pathology (Review). International Journal of Molecular Medicine 2001; 7: 3-12.
19. Parks WC. Matrix metalloproteinases in repair. Wound Repair and Regeneration 1999; 7: 423-432.
20. Paul RG, Tarlton JF, Purslow PP et al. Biomechanical and biochemical study of a standardized wound healing model. International Journal of Biochemistry and Cell Biology 1997; 29: 211-220.
21. Agren MS. Gelatinase activity during wound healing. British Journal of Dermatology 1994; 131: 634-640.
22. Wall SJ, Bevan D, Thomas DW et al. Differential expression of matrix metalloproteinases during impaired wound healing of the Diabetes mouse. Journal of Investigative Dermatology 2002; 91-98.
23. Ladwig GP, Robson MC, Liu R et al. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair and Regeneration 2002; 26-37.
24. Blalock TD, Varela JC, Gowda S et al. Ischemic skin wound healing models in rats. Wounds 2001; 13: 35-43.
25. Tervo T, Tervo K, van Setten GB et al. Plasminogen activator and its inhibitor in the experimental corneal wound. Experimental Eye Research 1989; 48: 445-449.
26. Tervo T, van Setten GB. Aprotinin for inhibition of plasmin on the ocular surface: principles and clinical observations. In: Healing Processes of the Cornea, (eds Beuerman RW, Crosson CE, Kaufman HE) Portfolio Publishing Company of Texas, The Woodlands, Texas, 1989; 151-163.
27. van Setten GB, Salonen EM, Vaheri A et al. Plasmin and plasminogen activator activities in tear fluid during corneal wound healing after anterior keratectomy. Current Eye Research 1989; 8: 1293-1298.
28. Cejkova J. Enzyme histochemistry of corneal wound healing. History and Histopathology 1998; 13: 553-564.
29. Cejkova J, Lojda Z, Dropcova S et al. The histochemical pattern of mechanically or chemically injured rabbit cornea after aprotinin treatment: relationships with the plasmin concentration of the tear fluid. Histochemistry Journal 1993; 25: 438-445.
30. Barlati S, Marchina E, Quaranta CA et al. Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair. Experimental Eye Research 1990; 51: 1-9.
31. Salonen EM, Tervo T, Torma E et al. Plasmin in tear fluid of patients with corneal ulcers: basis for new therapy. Acta Ophthalmologica (Copenhagen) 1987; 65: 3-12.
32. Vesaluoma M, Tervo T. Tear fluid changes after photorefractive keratectomy. Advances in Experimental and Medical Biology 1998; 438: 515-521.
33. Barro CD, Romanet JP, Fdili A et al. Gelatinase concentration in tears of corneal-grafted patients. Current Eye Research 1998; 17: 174-182.
34. Fini ME, Girard MT, Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmologica Supplement 1992; (Suppl): 26-33.
35. Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Archives of Dermatological Research 1998; 290 (Suppl.): S12-S23.
36. Lu PC, Ye H, Maeda M et al. Immunolocalization and gene expression of matrilysin during corneal wound healing. Investigative Ophthalmology and Visual Sciences 1999; 40: 20-27.
37. Matsubara M, Girard MT, Kublin CL et al. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Developments in Biology 1991; 147: 425-439.
38. Ye HQ, Azar DT. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Investigative Ophthalmology and Visual Sciences 1998; 39: 913-921.
39. van Setten GB. Epidermal growth factor in human tear fluid: increased release but decreased concentrations during reflex tearing. Current Eye Research 1990; 9: 79-83.
40. Ollivier FJ, Brooks DE, Kallberg ME et al. Evaluation of various compounds to inhibit activity of matrix metalloproteinases in the tear film of horses with ulcerative keratitis. American Journal of Veterinary Research 2003; 64: 1081-1087.